한글목차

세계 헬스케어 분석 시장 규모는 2024년 448억 3,000만 달러에서 2029년에는 1,331억 9,000만 달러에 달할 것으로 예상되며, 2024년부터 2029년까지 24.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

전자건강기록(EHR)의 보급이 헬스케어 분석 시장의 성장을 가속화하고 있습니다. 북미에서는 약 78%의 근무의사와 96%의 비연방 급성기 병원이 EHR 시스템을 사용하고 있으며, HITECH법 등의 규제 우대조치가 뒷받침하고 있습니다. 유럽의 EHR 도입률은 네덜란드의 경우 97%, 유럽 전체 평균은 81%로 다양하며, EHR 도입이 증가함에 따라 데이터에 대한 접근성이 향상되고, 고급 분석 솔루션에 대한 수요가 증가할 것으로 예상됩니다.

헬스케어 분석 시장은 용도별로 재무 애널리틱스, 임상 애널리틱스, 운영 및 관리 애널리틱스, 집단 건강 애널리틱스로 구분되며, 2023년에는 임상 애널리틱스 부문이 가장 큰 시장 점유율을 차지할 것으로 예측됩니다. 가치 기반 진료, 기술 발전, 환자 결과 개선, 결과 기반 성과, 비용 최적화, AI 및 EHR 시스템을 통한 개인화된 데이터 기반 진료 실현에 초점을 맞추면서 임상 분석의 성장이 촉진되고 있습니다. 이는 의료 서비스의 질과 효율성을 향상시키고, 헬스케어 분석 시장을 활성화할 수 있습니다.

지역별로는 아시아태평양의 헬스케어 분석 시장이 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 아시아태평양의 헬스케어 분석 시장은 미국에서는 3만-20만 달러인 반면, 아시아태평양의 평균 우회수술 비용은 약 4,000달러인 반면, 아시아태평양에서는 3만 달러에서 20만 달러로 저렴하게 의료 서비스를 이용할 수 있는 여건이 조성되면서 성장하고 있습니다. 또한, 의료관광에 대한 정부 지원, 의료 인프라 투자, IT의 확대, 만성질환을 앓고 있는 고령화 인구 증가는 아시아태평양의 세계 헬스케어 시장에서의 입지를 더욱 강화시키고 있습니다.

이 보고서는 세계 헬스케어 분석 시장을 조사했으며, 구성요소별/유형별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리한 보고서입니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 업계 동향
• 생태계 분석
• 밸류체인 분석
• 기술 분석
• 규제 분석
• 가격 분석
• Porter의 Five Forces 분석
• 특허 분석
• 주요 이해관계자와 구입 기준
• 최종사용자 분석
• 2024-2025년 주요 컨퍼런스 및 이벤트
• 사례 연구 분석
• 비즈니스 모델 분석
• 투자 및 자금조달 시나리오
• AI/생성형 AI가 헬스케어 분석 시장에 미치는 영향

제6장 헬스케어 분석 시장(컴포넌트별)

• 서론
• 서비스
• 소프트웨어

제7장 헬스케어 분석 시장(유형별)

• 서론
• 기술적 분석
• 예측 분석
• 처방 분석
• 진단 분석

제8장 헬스케어 분석 시장(용도별)

• 서론
• 재무
• 임상
• 운영 및 관리
• 인구 건강

제9장 헬스케어 분석 시장(최종사용자별)

• 서론
• 지불자
• 프로바이더
• 의약품 및 의료기기 공급망

제10장 헬스케어 분석 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제11장 경쟁 구도

• 서론
• 주요 시장 진출기업의 전략/강점, 2021년-2025년
• 매출 분석, 2019년-2023년
• 시장 점유율 분석, 2023년
• 기업 평가와 재무 지표
• 브랜드/소프트웨어 비교
• 기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 경쟁 시나리오

제12장 기업 개요

• 주요 시장 진출기업
  • MERATIVE
  • SAS INSTITUTE INC.
  • OPTUM, INC.
  • ORACLE
  • VERADIGM LLC
  • EXLSERVICE HOLDINGS, INC.
  • CITIUSTECH INC.
  • HEALTH CATALYST
  • CVS HEALTH
  • INOVALON
  • MCKESSON CORPORATION
  • MEDEANALYTICS, INC.
  • COTIVITI, INC.
  • APIXIO, INC.
  • ENLITIC
  • KOMODO HEALTH, INC.
  • HEALTHEC, LLC
  • IQVIA
  • WIPRO
• 기타 기업
  • ARCADIA SOLUTIONS, LLC.
  • EVIDATION HEALTH, INC.
  • HEALTHCORUM
  • AETION, INC.
  • TREDENCE.INC.
  • SISENSE LTD.

제13장 부록

영문목차

The global Healthcare analytics market is projected to reach 133.19 billion by 2029 from 44.83 billion in 2024, at a CAGR of 24.3 % from 2024 to 2029. The widespread adoption of Electronic Health Records (EHR) is accelerating the growth of the healthcare analytics market. In North America, approximately 78% of office-based physicians and 96% of non-federal acute care hospitals use EHR systems, which are supported by regulatory incentives such as the HITECH Act. Europe has varying adoption rates, with the Netherlands at 97% and an average of 81% across the continent, indicating a high potential for analytics integration. Increased adoption of EHRs improves data accessibility and drives the demand for advanced analytics solutions.

"Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period."

Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.

"APAC is estimated to register the highest CAGR during the forecast period."

In this report, the healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region's position in global healthcare.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

• By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 20%
• By Designation: C-level Executives - 50%, Directors - 30%, and Others - 20%
• By Region: North America- 40%, Europe - 35%, Asia Pacific- 20% and RoW- 5%

Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.

The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Government initiatives to increase EHR adoption, Growing venture capital investments in healthcare analytics start-ups, Growing pressure to curb healthcare spending and improve patient outcomes, Heterogeneity and complexity of big data in healthcare, Growing focus on real-world evidence, Cost Management and Operational Efficiency, Rise of Telemedicine and Remote Monitoring, Regulatory Compliance and Quality Improvement, Increasing demand for data-driven decision-making), restraints (High cost of analytics solutions in healthcare organizations, Rising data breach concerns), opportunities (Increasing focus on value-based medicines, Use of analytics in precision and personalized medicines, Cloud-based analytics, Increasing number of patient registries, Emergence of social media and its impact on healthcare industry, Augmented analytics to supplement human intelligence, Analytics of healthcare things), and challenges (Concerns regarding inaccurate and inconsistent data, Reluctance to adopt healthcare analytics solutions in emerging countries, Data integration for coordinated care, Operational gaps between payers and providers, Dearth of skilled personnel) influencing the growth of the healthcare analytics market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
• Market Development: Comprehensive information about lucrative markets - the report analyses the healthcare analytics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), Apixio. (US); among others in healthcare analytics market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Insights from primary experts
• 2.2 RESEARCH METHODOLOGY DESIGN
• 2.3 MARKET SIZE ESTIMATION METHODOLOGY
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
• 4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)
• 4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY
• 4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX
• 4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Favorable government initiatives for electronic health record adoption
    • 5.2.1.2 Growing venture capital investments in startups
    • 5.2.1.3 Need to reduce healthcare costs
    • 5.2.1.4 Increasing focus on real-world evidence
    • 5.2.1.5 Rise of telemedicine and remote patient monitoring
    • 5.2.1.6 Growing focus on regulatory compliance
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of analytics solutions
    • 5.2.2.2 Growing concerns about data breach
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing focus on value-based medicines
    • 5.2.3.2 Growing use of analytics in healthcare
    • 5.2.3.3 Rising number of patient registries
    • 5.2.3.4 Emergence of social media and digital health technologies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Concerns regarding inaccurate and inconsistent data
    • 5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
    • 5.2.4.3 Lack of maintenance of medical records
    • 5.2.4.4 Shortage of skilled personnel
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 INDUSTRY TRENDS
  • 5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
  • 5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
  • 5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Big data analytics
    • 5.7.1.2 Artificial intelligence and machine learning
    • 5.7.1.3 Business intelligence tools
  • 5.7.2 ADJACENT TECHNOLOGIES
    • 5.7.2.1 Cloud computing
    • 5.7.2.2 Internet of things
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
  • 5.8.2 GOVERNMENT REGULATIONS
    • 5.8.2.1 US
    • 5.8.2.2 Europe
    • 5.8.2.3 China
    • 5.8.2.4 Japan
    • 5.8.2.5 India
  • 5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
  • 5.9.2 AVERAGE SELLING PRICE, BY REGION
• 5.10 PORTER'S FIVE FORCES ANALYSIS
• 5.11 PATENT ANALYSIS
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
• 5.16 BUSINESS MODEL ANALYSIS
• 5.17 INVESTMENT AND FUNDING SCENARIO
• 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
  • 5.18.1 KEY USE CASES
  • 5.18.2 CASE STUDY ON AI/GEN AI
  • 5.18.3 ADJACENT MARKET ECOSYSTEM
    • 5.18.3.1 Life science analytics market
    • 5.18.3.2 Healthcare IT market
    • 5.18.3.3 Healthcare fraud analytics market
  • 5.18.4 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 Payers
      • 5.18.4.1.2 Providers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Payers
        • 5.18.4.2.1.1 Implementation
        • 5.18.4.2.1.2 Impact
      • 5.18.4.2.2 User B: Providers
        • 5.18.4.2.2.1 Implementation
        • 5.18.4.2.2.2 Impact

6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 SERVICES
  • 6.2.1 MANAGED SERVICES
    • 6.2.1.1 Analytical services
      • 6.2.1.1.1 Increasing volume of healthcare data to facilitate growth
    • 6.2.1.2 Consulting services
      • 6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth
  • 6.2.2 PROFESSIONAL SERVICES
    • 6.2.2.1 Training & implementation services
      • 6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market
    • 6.2.2.2 Maintenance & support services
      • 6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services
• 6.3 SOFTWARE
  • 6.3.1 ON-PREMISE SOFTWARE
    • 6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market
  • 6.3.2 CLOUD-BASED SOFTWARE
    • 6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption

7 HEALTHCARE ANALYTICS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 DESCRIPTIVE ANALYTICS
  • 7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
• 7.3 PREDICTIVE ANALYTICS
  • 7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
• 7.4 PRESCRIPTIVE ANALYTICS
  • 7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
• 7.5 DIAGNOSTIC ANALYTICS
  • 7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH

8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 FINANCIAL ANALYTICS
  • 8.2.1 CLAIMS PROCESSING
    • 8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth
  • 8.2.2 REVENUE CYCLE MANAGEMENT
    • 8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market
  • 8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
    • 8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
  • 8.2.4 RISK ADJUSTMENT & ASSESSMENT
    • 8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth
• 8.3 CLINICAL ANALYTICS
  • 8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
    • 8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
  • 8.3.2 CLINICAL DECISION SUPPORT
    • 8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market
  • 8.3.3 REPORTING & COMPLIANCE
    • 8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
  • 8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
    • 8.3.4.1 Growing adoption of electronic health records to fuel market
  • 8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE
    • 8.3.5.1 Strong government support for personalized medicine to sustain growth
  • 8.3.6 MEDICAL IMAGING ANALYTICS
    • 8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
• 8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
  • 8.4.1 SUPPLY CHAIN ANALYTICS
    • 8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
  • 8.4.2 WORKFORCE ANALYTICS
    • 8.4.2.1 Need for effective recruitment to favor growth
  • 8.4.3 STRATEGIC ANALYTICS
    • 8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
• 8.5 POPULATION HEALTH ANALYTICS
  • 8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH

9 HEALTHCARE ANALYTICS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PAYERS
  • 9.2.1 PRIVATE INSURANCE COMPANIES
    • 9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
  • 9.2.2 GOVERNMENT AGENCIES
    • 9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
• 9.3 PROVIDERS
  • 9.3.1 HOSPITALS & CLINICS
    • 9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
  • 9.3.2 POST-ACUTE CARE ORGANIZATIONS
    • 9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market
  • 9.3.3 AMBULATORY SURGERY CENTERS
    • 9.3.3.1 Need to control healthcare costs to support market
  • 9.3.4 OTHER PROVIDERS
• 9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
  • 9.4.1 MANUFACTURERS
    • 9.4.1.1 Growing adoption of digital technologies to drive market
  • 9.4.2 DISTRIBUTORS & WHOLESALERS
    • 9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market
  • 9.4.3 RETAILERS
    • 9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth

10 HEALTHCARE ANALYTICS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 High adoption of electronic health records to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Government initiatives to increase use of analytics in healthcare
  • 10.3.3 UK
    • 10.3.3.1 Availability of venture capital investments to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Strong financial support for digital health to augment market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing adoption of personalized medicine to drive market
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
  • 10.4.3 CHINA
    • 10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth
  • 10.4.4 INDIA
    • 10.4.4.1 Favorable government initiatives to fuel market
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growing adoption of digital solutions in healthcare to boost market
  • 10.5.3 MEXICO
    • 10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION AND FINANCIAL METRICS
• 11.6 BRAND/SOFTWARE COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Component footprint
    • 11.7.5.4 Application footprint
    • 11.7.5.5 End-user footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 MERATIVE
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions/Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 SAS INSTITUTE INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions/Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product/Solution launches/enhancements/approvals/ upgrades
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 OPTUM, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions/Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 ORACLE
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions/Services offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.4.3.2 Deals
      • 12.1.4.3.3 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 VERADIGM LLC
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions/Services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.5.3.2 Deals
      • 12.1.5.3.3 Expansions
      • 12.1.5.3.4 Other developments
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 EXLSERVICE HOLDINGS, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions/Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Other developments
  • 12.1.7 CITIUSTECH INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions/Services offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.7.3.2 Deals
      • 12.1.7.3.3 Expansions
      • 12.1.7.3.4 Other developments
  • 12.1.8 HEALTH CATALYST
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions/Services offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.8.3.2 Deals
  • 12.1.9 CVS HEALTH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Solutions/Services offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 INOVALON
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Solutions/Services offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.10.3.2 Deals
      • 12.1.10.3.3 Expansions
      • 12.1.10.3.4 Other developments
  • 12.1.11 MCKESSON CORPORATION
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions/Services offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
  • 12.1.12 MEDEANALYTICS, INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions/Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
      • 12.1.12.3.2 Other developments
  • 12.1.13 COTIVITI, INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Solutions/Services offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.13.3.2 Other developments
  • 12.1.14 APIXIO, INC.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Solutions/Services offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.14.3.2 Deals
  • 12.1.15 ENLITIC
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Solutions/Services offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.15.3.2 Deals
  • 12.1.16 KOMODO HEALTH, INC.
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Solutions/Services offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.16.3.2 Deals
  • 12.1.17 HEALTHEC, LLC
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products/Solutions/Services offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Deals
  • 12.1.18 IQVIA
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products/Solutions/Services offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Deals
  • 12.1.19 WIPRO
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products/Solutions/Services offered
• 12.2 OTHER PLAYERS
  • 12.2.1 ARCADIA SOLUTIONS, LLC.
  • 12.2.2 EVIDATION HEALTH, INC.
  • 12.2.3 HEALTHCORUM
  • 12.2.4 AETION, INC.
  • 12.2.5 TREDENCE.INC.
  • 12.2.6 SISENSE LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS